-
Fiocruz creates a 100% national ingredient for use in the rapid test for visceral leishmaniasis
Fiocruz Pernambuco has created a 100% national ingredient to be added to the rapid screening test for the diagnosis of visceral leishmaniasis (VL).
Learn more -
Fiocruz and Sanofi sign memorandum for new collaborations in immunization
Bio-Manguinhos and Sanofi signed a Memorandum of Understanding that reaffirms their mutual interest in establishing further collaborations in the field of immunization.
Learn more -
Fiocruz is a candidate for UNESCO World Heritage Site
Fiocruz complex in Manguinhos, in Northern Rio de Janeiro, is a candidate for World Heritage status by the United Nations Educational, Scientific and Cultural Organization (UNESCO).
Learn more -
Fiocruz participates in meeting in Cali to strengthen TGHN LAC partnerships
Representatives of Fiocruz were present during the TGHN LAC consortium meeting held on March 14th and 15th at the School of Public Health of the Faculty of Health at the University of Valle in Cali, Colombia.
Learn more
Welcome!
The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America, based in Brazil. Its mission is to produce, disseminate and share knowledge and technologies
|
|
|
|
||
|
|
|
|
|
|